Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Yuta Inagawa"'
Autor:
Hidekazu Kanetaka, Soichiro Shimizu, Yuta Inagawa, Daisuke Hirose, Naoto Takenoshita, Hirofumi Sakurai, Haruo Hanyu
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
The cingulate island sign (CIS) on fludeoxyglucose (FDG)-positron emission tomography (PET) is a supporting biomarker of dementia with Lewy bodies (DLB). Its diagnostic accuracy has only been investigated in FDG-PET, however. The present prospective
Externí odkaz:
https://doaj.org/article/c1c57627abff4173b82e15ba49ac9595
Autor:
Yuta Inagawa, Hidekazu Kanetaka, Akito Tsugawa, Shu Sakurai, Shuntaro Serisawa, Soichiro Shimizu, Hirofumi Sakurai, Haruo Hanyu
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Purpose: Although olfactory decline and visual hallucinations are useful in distinguishing dementia with Lewy bodies (DLB) from Alzheimer's disease (AD) in a clinical setting, neither is easy to evaluate objectively. The pareidolia test is used to as
Externí odkaz:
https://doaj.org/article/f419807fe6ea4ab1b7185bdaa47be0c3
Autor:
Yuta Inagawa, Yukiko Komeno, Satoshi Saito, Yuji Maenohara, Tetsuro Yamagishi, Hiroyuki Kawashima, Taku Saito, Keiko Abe, Kuniko Iihara, Yasumasa Hatada, Tomiko Ryu
Publikováno v:
Case Reports in Hematology, Vol 2019 (2019)
A 34-year-old woman was diagnosed with acute promyelocytic leukemia. Chemotherapy was administered following the JALSG APL204 protocol. Induction therapy with all-trans retinoic acid resulted in complete remission on day 49. She developed coccygeal p
Externí odkaz:
https://doaj.org/article/d5a7c518c8bf478fa932d2a09fab2b1e
Autor:
Yuta, Inagawa, Katsutoshi, Shioda, Rika, Kato, Tsuyoshi, Okada, Toshiyuki, Kobayashi, Shiro, Suda
Publikováno v:
International Journal of Psychiatry in Clinical Practice. 26:376-380
Electroconvulsive therapy (ECT) is an effective treatment of major depressive disorder (MDD). However, high relapse rates after ECT represent clinical problems. To date, influence of number of ECT sessions on relapse rate remains to be elucidated. We
Autor:
Shuntaro Serisawa, Daisuke Hirose, Aya Imanishi, Yusuke Ogawa, Haruo Hanyu, Shu Sakurai, Hidekazu Kanetaka, Akito Tsugawa, Yoshitsugu Kaneko, Takashi Kanbayashi, Hirofumi Sakurai, Naoto Takenoshita, Kentaro Hirao, Soichiro Shimizu, Yuta Inagawa
Publikováno v:
Journal of Alzheimer's Disease. 73:117-123
Background Recently, many studies have investigated the association between orexin A and Alzheimer's disease (AD). However, it remains to be determined whether the observed changes in orexin A levels are associated with pathological changes underlyin
Autor:
Shuntaro Serisawa, Yuta Inagawa, Yusuke Ogawa, Naoto Takenoshita, Soichiro Shimizu, Shu Sakurai, Yoshitsugu Kaneko, Hirofumi Sakurai, Hidekazu Kanetaka, Kentaro Hirao, Akito Tsugawa, Daisuke Hirose
Publikováno v:
Journal of Alzheimer's Disease. 77:539-541
The ongoing coronavirus disease 2019 (COVID-19) pandemic has substantially affected patients with dementia and their caregivers. However, we found not all Alzheimer’s disease (AD) patients were afraid of COVID-19 infection. Therefore, we investigat
Autor:
Kosuke Shimomura, Kei Noguchi, Yuta Inagawa, Hiroshi Yoshimoto, Shigeru Hosaka, Koso Egi, Koji Takeshita, Minako Akiyama
Publikováno v:
Nihon Toseki Igakkai Zasshi. 52:643-649
Autor:
Yuta Inagawa, Soichiro Shimizu, Hirofumi Sakurai, Naoto Takenoshita, Haruo Hanyu, Daisuke Hirose, Hidekazu Kanetaka
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Frontiers in Neurology
Frontiers in Neurology
The cingulate island sign (CIS) on fludeoxyglucose (FDG)-positron emission tomography (PET) is a supporting biomarker of dementia with Lewy bodies (DLB). Its diagnostic accuracy has only been investigated in FDG-PET, however. The present prospective
Autor:
Hidekazu Kanetaka, Akito Tsugawa, Shuntaro Serisawa, Hirofumi Sakurai, Haruo Hanyu, Yuta Inagawa, Shu Sakurai, Soichiro Shimizu
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Frontiers in Neurology
Frontiers in Neurology
Purpose: Although olfactory decline and visual hallucinations are useful in distinguishing dementia with Lewy bodies (DLB) from Alzheimer's disease (AD) in a clinical setting, neither is easy to evaluate objectively. The pareidolia test is used to as
Autor:
Akito Tsugawa, Yuta Inagawa, Hirofumi Sakurai, Daisuke Hirose, Naoto Takenoshita, Kentaro Hirao, Aya Imanishi, Takashi Kanbayashi, Soichiro Shimizu, Haruo Hanyu, Hidekazu Kanetaka
Publikováno v:
Psychogeriatrics : the official journal of the Japanese Psychogeriatric SocietyREFERENCES. 21(1)